Sterling Spa, based in Italy, is a pharmaceutical company that stands out with its certifications from FDA and EDQM.
They are recognized for Global leader in steroidal APIs
One of their notable products is NORGESTIMATE, with a corresponding US DMF Number 15649.
Remarkably, this DMF maintains an Active status since its submission on October 04, 2001, highlighting commitment to regulatory compliance.
Their GDUFA DMF Review was successfully complete, with a review date of April 23, 2013, and payment made on April 11, 2013, indicating their dedication to facilitating drug approvals, Categorized as Type II